查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2134676

代謝體學盒市場：全球市場預測，2026-2032年

Metabolomics Kit Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，代謝體學盒市場將成長至 191,254 億美元，複合年成長率為 13.21%。

主要市場統計數據
基準年 2025 8.0239億美元
預計年份：2026年 9.03億美元
預測年份：2032年 1,912,540,000 美元
複合年成長率 (%) 13.21%

代謝體學盒：概述

代謝體學盒可用於生物檢體中代謝物的製備、萃取、分離、鑑定和定量。其應用範圍涵蓋生物標記發現、藥物研發、臨床試驗、食品科學、農業和環境分析等領域。市場需求主要來自對可重複性工作流程、更廣泛的代謝物覆蓋範圍、更高的分析靈敏度以及與質譜和核磁共振（NMR）平台兼容性的追求。

工作流程標準化正在重塑代謝體學。

該領域的研究格局正從高度客製化的實驗室方案轉向標準化、品管的工作流程。研究人員越來越檢驗那些能夠減少樣品製備差異、包含經驗證的對照品、適用於多種樣品類型並與現有分析平台整合的試劑盒。此外，隨著實驗室對可重複性和更高效利用專業人員的需求不斷成長，多重分析、自動化、減少溶劑用量、增強穩定性以及更清晰的文件記錄等特性也影響著採購決策。

人工智慧的應用範圍正在從數據生成擴展到數據解讀。

人工智慧主要透過數據處理和解讀影響代謝體學。機器學習技術可以輔助峰值檢測、頻譜註釋、批次效應校正、特徵選擇、路徑分析和生物標記優先排序。這些應用透過將一致的樣品製備與更高品質的下游資料集聯繫起來，提升了精心設計的試劑盒的價值。然而，要使人工智慧驅動的見解能夠應用於臨床和監管領域，模型透明度、參考庫品質、標準化的元資料和獨立檢驗仍然至關重要。

區域趨勢反映了科研基礎設施和監管合規的成熟度。

北美匯聚了先進的生物醫學研究、製藥活動和成熟的質譜基礎設施。歐洲受益於強大的學術網路、合作研究計畫以及監管機構對分析品質的重視。亞太地區得益於中國、日本、韓國、印度和澳洲不斷擴展的生命科學能力，儘管各實驗室的自動化和標準化程度存在差異。在拉丁美洲，質譜技術在轉化研究以及食品和農業研究領域的應用日益廣泛，但獲取技術和技術支援的挑戰仍然嚴峻。在中東，透過對專業機構和醫療保健產業的投資，研究能力正在不斷發展；而非洲則在感染疾病、營養、農業和以本地為重點的生物醫學研究領域擁有獨特的發展機會。

不同經濟和製度群體之間的實施情況各不相同。

在東協市場，區域研究合作正在發展，並有望從互通的工作流程和在地化的技術支援中獲益。金磚國家成員國擁有強大的科學研究能力，但其採購、監管和基礎設施環境各不相同。歐盟強調協調、數據品質和跨境合作。七國集團（G7）國家普遍擁有成熟的分析生態系統，需要先進的自動化、檢驗和資訊整合。海灣合作理事會（GCC）正在加強其在生物醫學和臨床研究方面的能力，並日益重視穩健且使用者友好的工作流程。北約成員國的研究環境涵蓋高度發展到新興的各個階段，因此互通性、供應連續性和標準化協議尤其重要。

各國具體優先事項包括平台深度和能力建構等面向。

美國和加拿大重視轉化研究、藥物開發以及與先進分析平台的整合。英國、德國、法國、義大利和西班牙正在融合大學、醫院和產業界的研究，尤其注重可重複性和合作研究基礎設施。中國、日本和韓國正在拓展高通量、精準醫療和技術驅動型研究，而印度則在製藥、臨床和農業領域提升其應用能力。澳洲支持生物醫學、環境和農業領域的代謝體學。巴西和墨西哥在公共衛生、食品、農業和生物多樣性研究方面發揮著重要作用。俄羅斯的能力取決於其國內科研基礎設施、採購條件以及取得國際技術的管道。

我們優先考慮可複現性、互通性和基於證據的實施。

產業領導者在設計試劑盒時，應明確定義檢體類型​​，檢驗回收率，控制污染，並確保與常用分析平台相容。產品文件應包含操作規程、驗收標準、品管、穩定性資訊以及批次效應應對指南。與核心設施、醫院、大學和合約檢測實驗室建立合作關係，有助於改善工作流程檢驗和培訓。供應商還應加強數位化溯源，在可行的情況下支援自動化樣本製備，並為人工智慧驅動的分析結果提供透明的依據，而不是直接展示未經獨立檢驗的演算法輸出。

調查方法：整合跨應用和跨區域的證據。

本執行摘要對代謝體學盒領域進行了結構化、定性和綜合性的分析，重點關注工作流程要求、應用領域、分析技術、研究基礎設施、區域背景和推廣障礙。分析結果按目標區域、經濟和機構群體以及國家/地區進行分類。本評估強調可驗證的行業趨勢，包括標準化、自動化、分析相容性、數據品質、監管考慮和研究能力。市場估算與檢驗、市場規模計算、市場佔有率、預測、以及未經證實的公司特定聲明均已刻意排除在外。

可靠的工作流程是代謝體學實施下一階段的關鍵。

隨著實驗室尋求更具可重複性和擴充性的方法將生物樣本轉化為可解讀的分子數據，代謝體學盒的戰略重要性日益凸顯。其最大的發展機會在於經過檢驗的工作流程、廣泛的平台相容性、自動化、品質保證以及人工智慧的合理應用。儘管地區和國家的具體情況各不相同，但那些將技術能力與培訓、文件、互通性和透明的證據相結合的領導企業，最有能力支持代謝組學技術在研究、臨床、製藥、食品、農業和環境等領域的永續應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章代謝體學盒市場：依產品類型分類

  • 靶型套件
    • CE-MS靶材類型
    • GC-MS標靶類型
    • LC-MS標靶類型
  • 非目標套件
    • CE-MS非標靶型
    • GC-MS非標靶型
    • LC-MS非標靶型

第8章代謝體學盒市場：依技術分類

  • 質譜分析試劑盒
    • CE-MS試劑盒
    • GC-MS試劑盒
    • LC-MS試劑盒
  • 核磁共振試劑盒
    • 桌上型核磁共振試劑盒
    • 高場核磁共振試劑盒

第9章代謝體學盒市場：依應用領域分類

  • 農業研究
    • 作物改良
    • 土壤代謝體學
  • 臨床診斷
    • 生物標記發現
    • 疾病譜分析
  • 藥物發現與開發
    • 先導化合物的鑑定
    • 毒性篩檢
  • 環境分析
    • 代謝譜分析
    • 污染物監測
  • 食品和飲料分析
    • 污染測試
    • 品管

第10章：代謝體學盒市場：依最終用戶分類

  • 學術研究機構
    • 獨立研究機構
    • 大學
  • 生技公司
    • 生物製藥製造商
    • 生技新創企業
  • 受託研究機構
    • 臨床服務
    • 臨床前服務
  • 政府機構
    • 環保署
    • 藥品及醫療設備監管機構
  • 製藥公司
    • 學名藥生產商
    • 大型製藥企業

第11章代謝體學盒市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章代謝體學盒市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章代謝體學盒市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Agilent Technologies, Inc.
  • Biocrates Life Sciences AG
  • BioVision, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cayman Chemical Company
  • Chromadex, Inc.
  • Enzo Life Sciences, Inc.
  • Human Metabolome Technologies, Inc.
  • Leonardo Biosystems, Inc.
  • Merck KGaA
  • Metabolon, Inc.
  • New England BioLabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Roche Diagnostics
  • SCIEX (AB Sciex LLC)
  • Shimadzu Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

第16章 主要專家

Product Code: MRR-F774F6337031

The Metabolomics Kit Market is projected to grow by USD 1,912.54 million at a CAGR of 13.21% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 802.39 million
Estimated Year [2026] USD 900.03 million
Forecast Year [2032] USD 1,912.54 million
CAGR (%) 13.21%

Metabolomics Kits: Executive Overview

Metabolomics kits support the preparation, extraction, separation, identification, and quantification of metabolites from biological samples. Their use spans biomarker discovery, pharmaceutical research, clinical investigation, food science, agriculture, and environmental analysis. Demand is shaped by the need for reproducible workflows, broader metabolite coverage, higher analytical sensitivity, and compatibility with mass spectrometry and nuclear magnetic resonance platforms.

Workflow Standardization Is Reshaping Metabolomics

The landscape is shifting from highly customized laboratory protocols toward standardized, quality-controlled workflows. Researchers increasingly value kits that reduce sample-preparation variability, include validated controls, support diverse sample types, and integrate with established analytical platforms. Multiplexing, automation, solvent reduction, improved stability, and clearer documentation are also influencing purchasing decisions as laboratories seek stronger reproducibility and more efficient use of skilled personnel.

Artificial Intelligence Extends Interpretation Beyond Data Generation

Artificial intelligence is influencing metabolomics primarily through data processing and interpretation. Machine-learning methods can assist with peak detection, spectral annotation, batch-effect correction, feature selection, pathway analysis, and biomarker prioritization. These applications increase the value of well-designed kits by linking consistent sample preparation with higher-quality downstream datasets. However, model transparency, reference-library quality, standardized metadata, and independent validation remain essential before AI-derived findings are used in clinical or regulatory contexts.

Regional Patterns Reflect Research Infrastructure and Regulatory Readiness

North America combines advanced biomedical research, pharmaceutical activity, and established mass-spectrometry infrastructure. Europe benefits from strong academic networks, collaborative research programs, and regulatory attention to analytical quality. Asia-Pacific is supported by expanding life-science capabilities across China, Japan, South Korea, India, and Australia, while laboratories vary in automation and standardization maturity. Latin America shows growing use in translational research and food and agricultural studies, with access and technical-support considerations remaining important. The Middle East is developing research capacity through specialized institutions and healthcare investment, while Africa presents differentiated opportunities tied to infectious disease, nutrition, agriculture, and locally relevant biomedical research.

Economic and Institutional Groups Reveal Distinct Adoption Conditions

ASEAN markets are developing regional research links and may benefit from interoperable workflows and localized technical support. BRICS members combine substantial scientific capabilities with varied procurement, regulatory, and infrastructure conditions. The European Union emphasizes harmonization, data quality, and cross-border collaboration. G7 countries generally have mature analytical ecosystems and demand advanced automation, validation, and informatics integration. GCC countries are strengthening biomedical and clinical-research capacity, creating interest in robust, user-friendly workflows. NATO members span highly developed and emerging research environments, making interoperability, supply continuity, and standardized protocols particularly relevant.

Country-Level Priorities Range from Platform Depth to Capacity Building

The United States and Canada emphasize translational research, pharmaceutical development, and integration with advanced analytical platforms. The United Kingdom, Germany, France, Italy, and Spain combine university, hospital, and industrial research, with strong attention to reproducibility and collaborative infrastructure. China, Japan, and South Korea are expanding high-throughput, precision-health, and technology-enabled research, while India is broadening capabilities across pharmaceutical, clinical, and agricultural applications. Australia supports biomedical, environmental, and agricultural metabolomics. Brazil and Mexico show relevance in public health, food, agriculture, and biodiversity research. Russia's capabilities are shaped by domestic scientific infrastructure, procurement conditions, and access to international technologies.

Prioritize Reproducibility, Interoperability, and Evidence-Based Deployment

Industry leaders should design kits around clearly defined sample types, validated recovery performance, contamination control, and compatibility with commonly used analytical platforms. Product documentation should include protocols, acceptance criteria, quality controls, stability information, and guidance for handling batch effects. Partnerships with core facilities, hospitals, universities, and contract laboratories can improve workflow validation and training. Suppliers should also strengthen digital traceability, support automated preparation where practical, and establish transparent evidence for AI-enabled interpretation rather than presenting algorithmic outputs without independent validation.

Methodology: Evidence Synthesis Across Applications and Geographies

This executive summary uses a structured qualitative synthesis of the metabolomics-kit field, focusing on workflow requirements, application settings, analytical technologies, research infrastructure, regional conditions, and adoption barriers. Insights are organized across the requested regions, economic and institutional groups, and countries. The assessment emphasizes verifiable industry dynamics such as standardization, automation, analytical compatibility, data quality, regulatory considerations, and research capacity. It intentionally excludes market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Reliable Workflows Will Define the Next Stage of Metabolomics Adoption

Metabolomics kits are becoming strategically important as laboratories seek more reproducible and scalable paths from biological samples to interpretable molecular data. The strongest opportunities are associated with validated workflows, broad platform compatibility, automation, quality assurance, and responsible use of artificial intelligence. Regional and country-level conditions differ, but leaders that combine technical performance with training, documentation, interoperability, and transparent evidence will be best positioned to support durable adoption across research, clinical, pharmaceutical, food, agricultural, and environmental settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Metabolomics Kit Market, by Product Type

  • 7.1. Introduction
  • 7.2. Targeted Kits
    • 7.2.1. CE-MS Targeted
    • 7.2.2. GC-MS Targeted
    • 7.2.3. LC-MS Targeted
  • 7.3. Untargeted Kits
    • 7.3.1. CE-MS Untargeted
    • 7.3.2. GC-MS Untargeted
    • 7.3.3. LC-MS Untargeted

8. Metabolomics Kit Market, by Technology

  • 8.1. Introduction
  • 8.2. Mass Spectrometry Kits
    • 8.2.1. CE-MS Kits
    • 8.2.2. GC-MS Kits
    • 8.2.3. LC-MS Kits
  • 8.3. NMR Kits
    • 8.3.1. Benchtop NMR Kits
    • 8.3.2. High Field NMR Kits

9. Metabolomics Kit Market, by Application

  • 9.1. Introduction
  • 9.2. Agricultural Research
    • 9.2.1. Crop Improvement
    • 9.2.2. Soil Metabolomics
  • 9.3. Clinical Diagnostics
    • 9.3.1. Biomarker Discovery
    • 9.3.2. Disease Profiling
  • 9.4. Drug Discovery And Development
    • 9.4.1. Lead Identification
    • 9.4.2. Toxicology Screening
  • 9.5. Environmental Analysis
    • 9.5.1. Metabolic Profiling
    • 9.5.2. Pollutant Monitoring
  • 9.6. Food And Beverage Analysis
    • 9.6.1. Adulteration Testing
    • 9.6.2. Quality Control

10. Metabolomics Kit Market, by End User

  • 10.1. Introduction
  • 10.2. Academic And Research Institutes
    • 10.2.1. Independent Research Centers
    • 10.2.2. Universities
  • 10.3. Biotechnology Companies
    • 10.3.1. Biopharmaceutical Manufacturers
    • 10.3.2. Biotech Startups
  • 10.4. Contract Research Organizations
    • 10.4.1. Clinical Services
    • 10.4.2. Preclinical Services
  • 10.5. Government Agencies
    • 10.5.1. Environmental Protection Agencies
    • 10.5.2. Health Regulatory Agencies
  • 10.6. Pharmaceutical Companies
    • 10.6.1. Generic Pharma
    • 10.6.2. Large Pharma

11. Metabolomics Kit Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Metabolomics Kit Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Metabolomics Kit Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Agilent Technologies, Inc.
  • 15.2. Biocrates Life Sciences AG
  • 15.3. BioVision, Inc.
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. Bruker Corporation
  • 15.6. Cayman Chemical Company
  • 15.7. Chromadex, Inc.
  • 15.8. Enzo Life Sciences, Inc.
  • 15.9. Human Metabolome Technologies, Inc.
  • 15.10. Leonardo Biosystems, Inc.
  • 15.11. Merck KGaA
  • 15.12. Metabolon, Inc.
  • 15.13. New England BioLabs, Inc.
  • 15.14. PerkinElmer, Inc.
  • 15.15. Promega Corporation
  • 15.16. Roche Diagnostics
  • 15.17. SCIEX (AB Sciex LLC)
  • 15.18. Shimadzu Corporation
  • 15.19. Tecan Group Ltd.
  • 15.20. Thermo Fisher Scientific Inc.
  • 15.21. Waters Corporation

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Metabolomics Kit Market, Years Considered for the Study
  • FIGURE 2. Global Metabolomics Kit Market, Research Design
  • FIGURE 3. Global Metabolomics Kit Market, Research Framework
  • FIGURE 4. Global Metabolomics Kit Market, Data Triangulation
  • FIGURE 5. Global Metabolomics Kit Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Metabolomics Kit Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Metabolomics Kit Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Metabolomics Kit Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 9. Global Metabolomics Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Metabolomics Kit Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Metabolomics Kit Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Metabolomics Kit Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Metabolomics Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Metabolomics Kit Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Metabolomics Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Metabolomics Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Metabolomics Kit Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Metabolomics Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Metabolomics Kit Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Metabolomics Kit Market Segmentation & Coverage
  • TABLE 2. Global Metabolomics Kit Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Targeted Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Targeted Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Targeted Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global CE-MS Targeted Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global CE-MS Targeted Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global CE-MS Targeted Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global GC-MS Targeted Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global GC-MS Targeted Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global GC-MS Targeted Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global LC-MS Targeted Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global LC-MS Targeted Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global LC-MS Targeted Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Untargeted Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Untargeted Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Untargeted Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global CE-MS Untargeted Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global CE-MS Untargeted Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global CE-MS Untargeted Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global GC-MS Untargeted Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global GC-MS Untargeted Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global GC-MS Untargeted Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global LC-MS Untargeted Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global LC-MS Untargeted Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global LC-MS Untargeted Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 29. Global Mass Spectrometry Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Mass Spectrometry Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Mass Spectrometry Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global CE-MS Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global CE-MS Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global CE-MS Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global GC-MS Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global GC-MS Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global GC-MS Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global LC-MS Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global LC-MS Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global LC-MS Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global NMR Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global NMR Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global NMR Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Benchtop NMR Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Benchtop NMR Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Benchtop NMR Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global High Field NMR Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global High Field NMR Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global High Field NMR Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 51. Global Agricultural Research Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Agricultural Research Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Agricultural Research Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Crop Improvement Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Crop Improvement Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Crop Improvement Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Soil Metabolomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Soil Metabolomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Soil Metabolomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Biomarker Discovery Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Biomarker Discovery Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Biomarker Discovery Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Disease Profiling Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Disease Profiling Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Disease Profiling Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Drug Discovery And Development Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Drug Discovery And Development Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Drug Discovery And Development Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Lead Identification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Lead Identification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Lead Identification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Toxicology Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Toxicology Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Toxicology Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Environmental Analysis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Environmental Analysis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Environmental Analysis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global Metabolic Profiling Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Metabolic Profiling Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Metabolic Profiling Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global Pollutant Monitoring Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Global Pollutant Monitoring Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 86. Global Pollutant Monitoring Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 87. Global Food And Beverage Analysis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Global Food And Beverage Analysis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 89. Global Food And Beverage Analysis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 90. Global Adulteration Testing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Global Adulteration Testing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 92. Global Adulteration Testing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 93. Global Quality Control Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Global Quality Control Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 95. Global Quality Control Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 96. Global Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 97. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 99. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 100. Global Independent Research Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Global Independent Research Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 102. Global Independent Research Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 103. Global Universities Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 104. Global Universities Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. Global Universities Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 106. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 107. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 108. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 109. Global Biopharmaceutical Manufacturers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 110. Global Biopharmaceutical Manufacturers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 111. Global Biopharmaceutical Manufacturers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 112. Global Biotech Startups Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 113. Global Biotech Startups Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 114. Global Biotech Startups Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 115. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 116. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 117. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 118. Global Clinical Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 119. Global Clinical Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 120. Global Clinical Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 121. Global Preclinical Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 122. Global Preclinical Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 123. Global Preclinical Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 124. Global Government Agencies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 125. Global Government Agencies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 126. Global Government Agencies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 127. Global Environmental Protection Agencies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 128. Global Environmental Protection Agencies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 129. Global Environmental Protection Agencies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 130. Global Health Regulatory Agencies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 131. Global Health Regulatory Agencies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 132. Global Health Regulatory Agencies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 133. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 134. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 135. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 136. Global Generic Pharma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 137. Global Generic Pharma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 138. Global Generic Pharma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 139. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 140. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 141. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 142. Global Metabolomics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 143. Asia-Pacific Metabolomics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 144. Asia-Pacific Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 145. Asia-Pacific Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 146. Asia-Pacific Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 147. Asia-Pacific Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 148. Asia-Pacific Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 149. Asia-Pacific Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 150. Asia-Pacific Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 151. Asia-Pacific Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 152. Asia-Pacific Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 153. Asia-Pacific Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 154. Asia-Pacific Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 155. Asia-Pacific Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 156. Asia-Pacific Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 157. Asia-Pacific Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 158. Asia-Pacific Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 159. Asia-Pacific Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 160. Asia-Pacific Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 161. Asia-Pacific Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 162. North America Metabolomics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 163. North America Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 164. North America Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 165. North America Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 166. North America Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 167. North America Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 168. North America Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 169. North America Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 170. North America Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 171. North America Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 172. North America Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 173. North America Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 174. North America Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 175. North America Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 176. North America Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 177. North America Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 178. North America Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 179. North America Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 180. North America Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 181. Latin America Metabolomics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 182. Latin America Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 183. Latin America Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 184. Latin America Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 185. Latin America Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 186. Latin America Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 187. Latin America Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 188. Latin America Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 189. Latin America Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 190. Latin America Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 191. Latin America Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 192. Latin America Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 193. Latin America Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 194. Latin America Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 195. Latin America Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 196. Latin America Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 197. Latin America Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 198. Latin America Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 199. Latin America Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 200. Europe Metabolomics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 201. Europe Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 202. Europe Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 203. Europe Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 204. Europe Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 205. Europe Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 206. Europe Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 207. Europe Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 208. Europe Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 209. Europe Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 210. Europe Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 211. Europe Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 212. Europe Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 213. Europe Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 214. Europe Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 215. Europe Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 216. Europe Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 217. Europe Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 218. Europe Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 219. Middle East Metabolomics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 220. Middle East Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 221. Middle East Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 222. Middle East Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 223. Middle East Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 224. Middle East Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 225. Middle East Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 226. Middle East Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 227. Middle East Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 228. Middle East Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 229. Middle East Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 230. Middle East Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 231. Middle East Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 232. Middle East Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 233. Middle East Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 234. Middle East Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 235. Middle East Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 236. Middle East Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 237. Middle East Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 238. Africa Metabolomics Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 239. Africa Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 240. Africa Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 241. Africa Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 242. Africa Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 243. Africa Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 244. Africa Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 245. Africa Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 246. Africa Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 247. Africa Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 248. Africa Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 249. Africa Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 250. Africa Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 251. Africa Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 252. Africa Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 253. Africa Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 254. Africa Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 255. Africa Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 256. Africa Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 257. Global Metabolomics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 258. ASEAN Metabolomics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 259. ASEAN Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 260. ASEAN Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 261. ASEAN Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 262. ASEAN Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 263. ASEAN Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 264. ASEAN Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 265. ASEAN Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 266. ASEAN Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 267. ASEAN Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 268. ASEAN Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 269. ASEAN Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 270. ASEAN Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 271. ASEAN Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 272. ASEAN Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 273. ASEAN Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 274. ASEAN Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 275. ASEAN Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 276. ASEAN Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 277. GCC Metabolomics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 278. GCC Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 279. GCC Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 280. GCC Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 281. GCC Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 282. GCC Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 283. GCC Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 284. GCC Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 285. GCC Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 286. GCC Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 287. GCC Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 288. GCC Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 289. GCC Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 290. GCC Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 291. GCC Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 292. GCC Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 293. GCC Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 294. GCC Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 295. GCC Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 296. European Union Metabolomics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 297. European Union Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 298. European Union Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 299. European Union Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 300. European Union Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 301. European Union Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 302. European Union Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 303. European Union Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 304. European Union Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 305. European Union Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 306. European Union Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 307. European Union Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 308. European Union Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 309. European Union Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 310. European Union Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 311. European Union Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 312. European Union Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 313. European Union Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 314. European Union Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 315. BRICS Metabolomics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 316. BRICS Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 317. BRICS Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 318. BRICS Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 319. BRICS Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 320. BRICS Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 321. BRICS Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 322. BRICS Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 323. BRICS Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 324. BRICS Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 325. BRICS Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 326. BRICS Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 327. BRICS Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 328. BRICS Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 329. BRICS Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 330. BRICS Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 331. BRICS Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 332. BRICS Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 333. BRICS Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 334. G7 Metabolomics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 335. G7 Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 336. G7 Metabolomics Kit Market Size, by Targeted Kits, 2017-2032 (USD Million)
  • TABLE 337. G7 Metabolomics Kit Market Size, by Untargeted Kits, 2017-2032 (USD Million)
  • TABLE 338. G7 Metabolomics Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 339. G7 Metabolomics Kit Market Size, by Mass Spectrometry Kits, 2017-2032 (USD Million)
  • TABLE 340. G7 Metabolomics Kit Market Size, by NMR Kits, 2017-2032 (USD Million)
  • TABLE 341. G7 Metabolomics Kit Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 342. G7 Metabolomics Kit Market Size, by Agricultural Research, 2017-2032 (USD Million)
  • TABLE 343. G7 Metabolomics Kit Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 344. G7 Metabolomics Kit Market Size, by Drug Discovery And Development, 2017-2032 (USD Million)
  • TABLE 345. G7 Metabolomics Kit Market Size, by Environmental Analysis, 2017-2032 (USD Million)
  • TABLE 346. G7 Metabolomics Kit Market Size, by Food And Beverage Analysis, 2017-2032 (USD Million)
  • TABLE 347. G7 Metabolomics Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 348. G7 Metabolomics Kit Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
  • TABLE 349. G7 Metabolomics Kit Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 350. G7 Metabolomics Kit Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 351. G7 Metabolomics Kit Market Size, by Government Agencies, 2017-2032 (USD Million)
  • TABLE 352. G7 Metabolomics Kit Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 353. NATO Metabolomics Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 354. NATO Metabolomics Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 355. NATO Metabol